source
- Catalent to sell its Nottingham oral solid dose facility to CDMO CodisCatalent announced it will divest its United Kingdom manufacturing site, selling the oral solid dose factory located in Nottingham. The buyer is Codis, a contract development and manufacturing org…
- Prime Medicine clears legal hurdle with Beam Therapeutics, moves AATD gene therapy toward clinicPrime Medicine announced it will advance its AATD gene editing candidate into clinical trials after arbitrators ruled in its favor in a dispute with Beam Therapeutics. The dispute centered on a 20…